The Remineralization of Early Enamel Caries in Permanent Teeth
Clinical Evaluation of Biomimetic Self -Assembling Peptide (p11-4) in The Remineralization of Early Enamel Caries in Permanent Teeth
1 other identifier
interventional
50
1 country
1
Brief Summary
Evaluate clinically the remineralizing potential of self-assembling peptide ( P11-4) fluoride plus in early enamel carious lesions of permanent anterior teeth.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_1
Started Jun 2024
Shorter than P25 for phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 29, 2024
CompletedFirst Posted
Study publicly available on registry
April 10, 2024
CompletedStudy Start
First participant enrolled
June 6, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 6, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 6, 2025
CompletedMay 23, 2024
May 1, 2024
5 months
March 29, 2024
May 21, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Remineralization potential
T0:baseline assessment --\> T1:1 month(Application of Curodont repair flouride plus /fluoride varnish andAssessment of white spot lesion regression)--\> T2: 3 months Assessment of white spot lesion regression\_\_\>T3: 6 months assessment of white spot lesion regression by: Inspection under magnification ICDAS II Score 0:Sound tooth surface: 1. First visual change in enamel. 2. Distinct visual change in enamel visible when wet, lesion must be visible when dry. by:Diagnodent
1 month
Secondary Outcomes (1)
Remineralization potential
3 months
Study Arms (2)
curodont repair fluoride plus
EXPERIMENTALGroup I (study group): Teeth will be treated with self-assembling peptide (P11-4) fluoride plus varnish.
fluoride varnish
ACTIVE COMPARATORGroup II (control group): Teeth will be treated with fluoride varnish.
Interventions
Self-assembling peptide (P11-4) fluoride plus will be applied according to the manufacturer's instructions by pushing the two cylinders together and will left for 5 min till the tooth surface appears dry to insure its diffusion The remineralizing process of the early enamel carious lesions will be assessed quantitatively using the laser fluorescence DIAGNOdent measuring and assessed qualitatively using ICDAS II scoring system at baseline 1, 3, 6 months post-treatment
Fluoride varnish will be applied under manufacturer instructions by applying thin layer of varnish with a brush in strokes The remineralizing process of the early enamel carious lesions will be assessed quantitatively using the laser fluorescence DIAGNOdent measuring and assessed qualitatively using ICDAS II scoring system at baseline 1, 3, 6 months post-treatment
Eligibility Criteria
You may qualify if:
- Presence of active non-cavitated carious white spot lesions with DIAGNO/dent reading from 5 to 17 ,on labial surfaces of permanent anterior teeth and International Caries Detection And Assessment System II (ICDAS II) ranging between 1 and 3.
- The children' age range between 10 to14 years old.
- Children had completed fixed orthodontic treatment within the past week.
- Good oral hygiene with a plaque index score 0 or 1.
- No systemic diseases or medication affecting salivary flow.
You may not qualify if:
- Children with tetracycline pigmentation, dental fluorosis, or enamel hypoplasia.
- Children had fluoride application less than 3 months before the study.
- Presence of restoration and cavitation on the surface to be treated.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Tanta Universitylead
Study Sites (1)
faculty of Dentistry,Tanta university
Tanta, 31511, Egypt
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- principal investigator
Study Record Dates
First Submitted
March 29, 2024
First Posted
April 10, 2024
Study Start
June 6, 2024
Primary Completion
November 6, 2024
Study Completion
January 6, 2025
Last Updated
May 23, 2024
Record last verified: 2024-05
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- 6 months